Login / Signup

Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.

Barbara VigoneMonica CaronniAdriana SeverinoChiara BellocchiAnna Rita BaldassarriMirella FraquelliGaia MontanelliAlessandro SantanielloLorenzo Beretta
Published in: Arthritis research & therapy (2017)
EU Clinical Trial Registry, EudraCT2012-005348-92 . Registered on 19 February 2013.
Keyphrases
  • systemic sclerosis
  • clinical trial
  • open label
  • interstitial lung disease
  • phase ii
  • study protocol
  • phase iii
  • phase ii study
  • randomized controlled trial
  • radiation therapy
  • combination therapy
  • double blind